Stem cell therapy: A promising treatment for COVID-19

作     者：Zhi-Xue Zheng 

作者机构：Department of General SurgeryBeijing Jishuitan HospitalBeijing 100035China 

出 版 物：《World Journal of Clinical Cases》 (世界临床病例杂志)

年 卷 期：2021年第9卷第36期

页      面：11148-11155页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：COVID-19 SARS-CoV-2 Mesenchymal stem cells Pandemic Stem cell therapy 

摘      要：Novel coronavirus disease 2019(COVID-19)caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has become a global ***-2 is an RNA virus and has a glycosylated spike(S)protein used for genome ***-19 can lead to a cytokine storm and patients usually have early respiratory signs and further secondary infections,which can be ***-19 has entered an emergency phase,but there are still no specific effective drugs for this *** stem cells(MSCs)are multipotent stromal cells,which cause antiapoptosis and can repair damaged epithelial *** clinical trials have proved that MSC therapy could be a potential feasible therapy for COVID-19 patients,especially those with acute respiratory distress syndrome,without serious adverse events or ***,more studies are needed in the future,in order to confirm the effect of this therapy.